Drug Use and Addiction Research Programs federal funding in FY2024

Addiction research × FY2024

Drug Use And Addiction Research Programs and FY2024 meet here because USAspending.gov tagged assistance actions with CFDA 93.279 and a fiscal-year key of 2024. $10,081,254,592.06 is that intersection. It is not the government-wide FY2024 total, not an outlay, and not a named-laboratory roster. CFDA 93.279 is Drug Use and Addiction Research Programs, an extramural research line, not a treatment-services CFDA and not a named-PI directory. The program hub /programs/93.279/ drops the year filter. The year hub /fiscal-years/2024/ drops the CFDA filter. Only this tie applies both.

FEC contribution files do not pay drug-use and addiction research awards. A reader who assigns $10,081,254,592.06 to 3,670 addiction clinics adds a label the facts do not carry. Other years on CFDA 93.279 remain outside this cell. Other CFDAs in FY2024 remain on the year hub. Confusing this join with SAMHSA 93.243, mental-health research (93.242), or NIDDK (93.847) would be a different table.

CFDA 93.279 is research, not SAMHSA services

USAspending labels CFDA 93.279 as Drug Use And Addiction Research Programs. That code produced $10,081,254,592.06 when filtered to FY2024. The program extract totals $11,966,347,937.16. FY2024's share is 84.2%. Remaining dollars on 93.279 sit in other fiscal years. Packet facts do not split recipients, places of performance, or award types. This page will not invent contractors. 5,019 is the parent award-record count, not a FY2024-only census when the two counts differ.

FY2024 research dollars inside the 93.279 book

FY2024 is a fiscal-year bucket on the yearlyTrend series, not every NIDA grant year closed in calendar 2024. Later bulk files can move $10,081,254,592.06 without changing the join keys. Awards that carry a different year sit outside even if the CFDA is still 93.279. The 84.2% figure describes this join, not a ranking of programs as winners or losers. Open /programs/ for the CFDA index and /ties/ for other spending ties.

3,670 awards are not 3,670 clinics

3,670 awards describe the drug-use and addiction research × FY2024 cell. That count is not 3,670 addiction clinics. The implied mean of about $2,746,935.86 divides $10,081,254,592.06 by 3,670; it is a quotient, not a typical assistance invoice. Modifications add rows. Unique vendors are unpublished. Do not read 3,670 as 3,670 finished projects under drug-use and addiction research. The parent 5,019 count is larger than the year slice when other years exist on the same CFDA.

Research obligations versus grant cash already drawn

$10,081,254,592.06 is an obligation aggregate. Treasury outlays can lag or differ and are unpublished here. Keep both keys in any citation: Drug Use And Addiction Research Programs (CFDA 93.279) and FY2024. Prefer live tables at /programs/93.279/ and /fiscal-years/2024/ if a later ingest restates the snapshot. All programs (/programs/) and All spending ties (/ties/) are larger than this cell. The join is not SAMHSA 93.243, mental-health research (93.242), or NIDDK (93.847).

Reuse $10,081,254,592.06 only with Drug Use And Addiction Research Programs and FY2024 in the same sentence. Original filings remain on USAspending.gov. Campaign-finance tables remain a separate dataset. Unique recipients remain unpublished on this program-year join. a named-laboratory roster is outside the packet. Keep Drug Use And Addiction Research Programs and FY2024 together when citing $10,081,254,592.06. CFDA 93.279 and fiscal year 2024 are the join keys. Obligations of $10,081,254,592.06 are not outlays. Original filings remain on USAspending.gov for this pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this program-year join. The All programs index and All spending ties index are larger than this cell.

Questions

What share of drug-use and addiction research sits in FY2024?

About 84.2%: $10,081,254,592.06 in FY2024 against a program-wide $11,966,347,937.16 on CFDA 93.279. That percentage locates the year inside the program book. It does not rank programs and is not an outlay share. USAspending.gov is the source.

Is $10,081,254,592.06 cash already paid in FY2024?

No. $10,081,254,592.06 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for drug-use and addiction research in FY2024. Keep both the CFDA number 93.279 and the fiscal year in the citation.

Do 3,670 awards mean 3,670 addiction clinics?

No. 3,670 is the FY2024 award-record count on CFDA 93.279, not 3,670 addiction clinics. Unique recipients are unpublished. The implied mean is about $2,746,935.86, a quotient, not a typical award. Original filings remain on USAspending.gov.

Which pages parent drug-use and addiction research in FY2024?

CFDA 93.279 at /programs/93.279/ is the program parent. FY2024 federal spending at /fiscal-years/2024/ is the year parent. All programs at /programs/ lists CFDA hubs. All spending ties at /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Drug Use And Addiction Research Programs × FY2024 at $10,081,254,592.06.